Professor, Pathology, University of Pittsburgh School of Medicine
Pathology
Dr. Michael A. Nalesnik, MD
|
|
Give Review
Michael Nalesnik works in the field of Pathology. He went to medical school at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine He received 1 awards: "Who's Who in America". Michael Nalesnik has written publications. He has 53 publications published with PubMed. The lastest publication is: 'Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice.' Michael Nalesnik accepts Medicare.
Publications
- Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
- An update on donor-derived disease transmission in organ transplantation.
- Communication Gaps Associated With Donor-Derived Infections.
- Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice.
- Neuroendocrine carcinoma of the extrahepatic bile duct: Case report and literature review.
- Plasma cell tumors in transplant patients.
- Despite the best intentions cancer is transmissible by transplantation.
- Growth factor pathways in development and progression of hepatocellular carcinoma.
- Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring?
- EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue in the Posttransplant Setting: A Distinct Type of Posttransplant Lymphoproliferativ...
- Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia.
- Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa.
- Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs.
- Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.
- Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.
- Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.
- Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function.
- Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection.
- Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinoma.
- Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.
- Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
- Altered liver morphology after portal vein thrombosis: not always cirrhosis.
- Expression of specific hepatocyte and cholangiocyte transcription factors in human liver disease and embryonic development.
- Unresectable hepatocellular carcinoma with a solitary metastasis to the mandible.
- Posttransplant adenoviral enteropathy in patients with small bowel transplantation.
- Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantation.
- Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature.
- Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders.
- Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
- Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.
- Histopathologic characteristics of human intestine allograft acute rejection in patients pretreated with thymoglobulin or alemtuzumab.
- NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
- Donor graft adenoviral iNOS gene transfer ameliorates rat liver transplant preservation injury and improves survival.
- Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy.
- Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.
- 3D-confocal structural analysis of bone marrow-derived renal tubular cells during renal ischemia/reperfusion injury.
- Posttransplant lymphoproliferative disorder among renal transplant patients in relation to the use of mycophenolate mofetil.
- Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide.
- Biliverdin protects the functional integrity of a transplanted syngeneic small bowel.
- De novo malignancies after intestinal and multivisceral transplantation.
- Gatifloxacin-induced hepatotoxicity and acute pancreatitis.
- Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury.
- Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts.
- Morphology and function of canine small intestinal autografts: with particular interest in the influence of ex vivo graft irradiation.
- Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
- A schema for histologic grading of small intestine allograft acute rejection.
- Posttransplant lymphoproliferative disorders presenting at sites of previous surgical intervention.
- Protective effects of ex vivo graft radiation and tacrolimus on syngeneic transplanted rat small bowel motility.
- Severe cholestatic hepatitis in a patient taking acitretin.
- On the crossroad between tolerance and posttransplant lymphoma.
- Reversal of Graft-Versus-Host Disease with Infusion of Stored Autologous Bone Marrow Cells Following Combined Liver-Bone Marrow Allotransplantation in Man.
- Experience with posttransplant lymphoproliferative disorders in solid organ transplant recipients.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Doctors Specialties
- Pathology
Accepted Insurances
Awards
- Who's Who in America
Education
-
University of Pittsburgh Medical Center -
Rutgers Robert Wood Johnson Medical School
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730155706 |
| Last Name Of The Provider | NALESNIK |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Anthony J. Demetris, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Rajiv Dhir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alyssa M. Krasinskas, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Steven Swerdlow, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Anna Mnuskin, MD |
|
|
Dr. Ramana Surampudi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bevan Tandon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amber H. Henry, MD |
|
|
Dr. Gutti R. Rao, MD |
|
|
Dr. Heather L. Stevenson-Lerner, MD |
|
|
Dr. Mark H. Yazer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Jianwu Xie
This Doctor is OpenDoctor Recommended.
|